Medicine
More
-
Shares of Jazz Pharmaceuticals PLC slid Wednesday morning, a day after the Irish drugmaker said in a regulatory filing that the Food and Drug Administration could approve a competitor's generic version of its top-seller, narcolepsy treatment Xyrem.
-
HARRISBURG, Pa.-- The latest stop for a Republican-penned bill to limit insurance coverage of abortions sparked an angry debate Tuesday among senators, reviving arguments over President Barack Obama's health care law and the case of a Philadelphia abortion doctor accused of killing a patient and four babies.
-
WASHINGTON-- Weight-loss surgery such as the type that New Jersey Gov. Chris Christie underwent may not just improve people's waistlines, but their health. Jaime Ponce, president of the American Society for Metabolic and Bariatric Surgery. "
-
By Sharon Begley and Ransdell Pierson. May 7- New Jersey Governor Chris Christie's choice of gastric banding has prompted questions about why he opted for a weight-loss procedure less favored by bariatric surgeons and patients.
-
*FDA sees long-term consequences in recruitment, future leadership. Participants at the Reuters Health Summit in New York this week spoke to the immediate impact of $85 billion in automatic government-wide budget cuts that began on March 1.
-
NEW YORK, May 7- In a blow for Alzheimer's patients, Baxter International Inc said it will scrap late-stage trials of its antibody treatment for the disease after the drug failed to improve cognitive decline and functional ability in patients.
-
NEW YORK, May 7- Only half of people in the United States who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, U.S. health officials said on Tuesday.
-
NEW YORK, May 7- In a blow for Alzheimer's patients, Baxter International Inc said it will scrap late-stage trials of its antibody treatment for the disease after the drug failed to improve cognitive decline and functional ability in patients.
-
May 7- Baxter International Inc said it will stop developing a drug for treating mild to moderate Alzheimer's disease after a late-stage study showed it failed to reduce the decline of cognitive functions and preserve functional abilities in patients. They closed at $70.31 on the New York Stock Exchange on Monday.
-
May 7- Baxter International Inc said a late-stage study of its experimental drug to treat Alzheimer's disease failed to reduce the decline of cognitive functions and preserve functional abilities.
-
*The scripps research institute announces new research and license agreement. *The scripps research institute- agreement with janssen to collaborate on. focused research projects in infectious disease area.
-
CAMBRIDGE, Mass.-- Ariad Pharmaceuticals Inc. said Tuesday that revenue from its leukemia pill Iclusig, its first approved drug, totaled $6.4 million in the first quarter, surpassing Wall Street's expectations. The Food and Drug Administration approved Iclusig in December as a treatment for two types of the disease.
-
NEW YORK, May 7- Stepping into the debate over who should be screened for lung cancer, a leading medical specialty group issued new guidelines on Tuesday recommending that doctors offer annual low-dose CT scanning to people whose age and smoking history puts them at significant risk of lung cancer.
-
BEIJING, May 7- Four more people in China have died from a new strain of bird flu, bringing to 31 the number of deaths from the mysterious H7N9 virus, with the number of infections rising by two to 129, according to Chinese health authorities.
-
NEW YORK-- Two analysts starting covering biotech drugmaker Chimerix Inc. with top ratings on Monday, pointing to the company's experimental drug CMX001.
-
High frequency trading has become such a hot topic, it's now the subject of a new movie called "Ghost Exchange," with Camilla Sullivan, director of the film.
-
NEW YORK, May 6- The head of the U.S. Centers for Disease Control and Prevention says the current strain of bird flu that is causing illness and deaths in China cannot spark a pandemic in its current form- but he added that there is no guarantee it will not mutate and cause a serious pandemic. In an exclusive interview at the Reuters Health Summit in New York, Dr.
-
May 6- Roche Holding AG:. *US FDA warns use of short version of Roche Holding's breast cancer. *FDA says dosing, treatment schedules for Roche's Kadcyla and Herceptin are.
-
*Abbvie's investigational hcv regimen receives breakthrough therapy. designation from the U.S. food and drug administration. *Says interferon-free, direct-acting antiviral combination therapy currently.
-
Following is Cramer's homework on a lesser-known stock called to his attention by viewers.